Holds 2 active US DMFs and 2 valid CEPs for pantoprazole, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
EDQM certificate database
FDA, List of Drug Master Files
Holds 2 active US DMFs and 2 valid CEPs for pantoprazole, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and one valid CEP for pantoprazole, filing since 2007. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and 4 valid CEPs for pantoprazole, filing since 2008. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one active US DMF and one valid CEP for pantoprazole, filing since 2023. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 6 markets.
Holds one active US DMF and 4 valid CEPs for pantoprazole, filing since 2004. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds 4 active US DMFs and one valid CEP for pantoprazole, filing since 2020. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 14 markets.
Holds 2 active US DMFs and 2 valid CEPs for pantoprazole, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.
Holds one active US DMF and one valid CEP for pantoprazole, filing since 2019. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF and 3 valid CEPs for pantoprazole, filing since 2021. Its 2019 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for pantoprazole, filing since 2007. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 valid CEPs for pantoprazole, filing since 2023. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 4 active US DMFs for pantoprazole, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF and 2 valid CEPs for pantoprazole, filing since 2015. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for pantoprazole, filing since 2022. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for pantoprazole, filing since 2011. Its 2025 FDA inspection closed as NAI.
Holds one valid CEP for pantoprazole, filing since 2017. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 15 markets.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Pantoprazole manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free